These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11268916)

  • 1. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
    Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Europe ready for STD screening?
    Mårdh PA
    Genitourin Med; 1997 Apr; 73(2):96-8. PubMed ID: 9215088
    [No Abstract]   [Full Text] [Related]  

  • 5. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of gram-stained cervical smear from patients with Chlamydia trachomatis infection.
    Raddi MS; Vidal AF; Santana DM
    Rev Latinoam Microbiol; 1993; 35(2):159-61. PubMed ID: 8209109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
    Chen S; Li J; van den Hoek A
    Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.
    Novak DP; Lindholm L; Jonsson M; Karlsson RB
    Scand J Public Health; 2004; 32(5):324-32. PubMed ID: 15513664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 10. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chlamydia trachomatis. Screening of pregnant women].
    Skjeldestad FE; Dalen A; Buhaug H; Bakketeig LS
    Tidsskr Nor Laegeforen; 1987 Sep; 107(25):2129-31. PubMed ID: 3672446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Screening for Chlamydia trachomatis infection: which target group and at what price?].
    Postma MJ; van den Hoek JA
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1237-8. PubMed ID: 10428675
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A German Chlamydia trachomatis screening program employing semi-automated real-time PCR: results and perspectives.
    Böhm I; Gröning A; Sommer B; Müller HW; Krawczak M; Glaubitz R
    J Clin Virol; 2009 Nov; 46 Suppl 3():S27-32. PubMed ID: 20129071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chlamydia trachomatis infection in women seeking termination of pregnancy 1985-2000].
    Bakken IJ; Skjeldestad FE; Nordbø SA
    Tidsskr Nor Laegeforen; 2004 Jun; 124(12):1638-40. PubMed ID: 15229710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia trachomatis during pregnancy. To screen or not to screen?
    Carroll JC
    Can Fam Physician; 1993 Jan; 39():97-102. PubMed ID: 8435566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening pregnant women for Chlamydia--Quebec.
    Auger P; Désilets J; Bernard D; Roussin ML; Poliquin J; Robert J; Steben M
    Can Dis Wkly Rep; 1990 Mar; 16(10):45-6. PubMed ID: 2322947
    [No Abstract]   [Full Text] [Related]  

  • 20. The chlamydia problem in New Zealand.
    Perkins N
    N Z Med J; 2004 May; 117(1194):U887. PubMed ID: 15156205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.